Ex vivo data have shown IL-1β expression to be highly upregulated in pancreatic islets of patients with T2DM2 and human β-cells to be prone to both IL-1β–induced destruction and functional impairment,3,4 indicating a possible role of IL-1β in T2DM progression. This evidence concerns the gene IL1B and type 2 diabetes mellitus.